InvestorsHub Logo

OTCShotCaller

08/15/22 11:01 AM

#112169 RE: Schuller #112136

Thank your for that Revelation!

Much appreciated however I was under the impression that Eli Lilly had developed an NR2F6 Checkpoint inhibitor that's not identical to ours.

Best wishes